Management Approach for Residual and Recurrent Mitral Regurgitation After Transcatheter Edge-to-Edge Repair

Authors

• Jonathan X. Fang
• Gennaro Giustino
• Kent Chak-Yu So
• Lukas Stolz
• Mateo Marin-Cuartas
• Annette Maznyczka
• Suzanne J. Baron
• Jaffar M. Khan
• Mi Chen
• Ahmad Jabri, Corewell Health East

Document Type

Article

Publication Date

5-11-2026

Abstract

Mitral valve transcatheter edge-to-edge repair (M-TEER) is an established treatment option for patients with severe mitral regurgitation (MR) at high risk for surgery. However, the rate of recurrent MR ≥ 3+ after M-TEER may be up to 10% at 1 year. As the volume of M-TEER procedures increases, the number of patients experiencing recurrent MR post-TEER is also rising. M-TEER reshapes valve anatomy and complicates further treatment strategies for MR. In this review, the authors provide practical management considerations for patients with residual or recurrent MR after M-TEER.

Volume

19

Issue

9

First Page

1071

Last Page

1086

Recommended Citation

Fang JX, Giustino G, So KC, Stolz L, Marin-Cuartas M, Maznyczka A, et al [Ahmad J] Management approach for residual and recurrent mitral regurgitation after transcatheter edge-to-edge repair. JACC Cardiovasc Interv. 2026 May 11;19(9):1071-1086. doi: 10.1016/j.jcin.2026.02.045. PMID: 42120115.

DOI

10.1016/j.jcin.2026.02.045